Notes / Company

Jagsonpal Pharmaceuticals Ltd.

JAGSNPHARM BSE 507789 ISIN INE048B01035 Pharmaceuticals

Fundamentals

Market cap: ₹1,471 cr
P/E: 34.15×
ROE: 23.07%
Debt / equity: 0.00
Div yield: 1.74%
52-week range: 155.00 — 301.65

Research on Tijori Finance

Company snapshot

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals

₹1,554 cr

P/E 36.07×

Latest quarter · Mar 2026

Sales₹64 cr

Net profit₹9 cr

Op. margin+17.4%

EPS₹1.31

Strength & growth

Debt / equity0.00×

Current ratio6.22×

Sales CAGR+7.1%

EPS CAGR+28.3%

The timeline — 1 note on Jagsonpal Pharmaceuticals Ltd.

June 2026

29 Jun 26 · 4:32 PM IST Lead

Lead · M&A · Small cap

Jagsonpal Pharma buys hospital distributor for ₹20.8 cr

The cash deal adds ₹53 cr in revenue and a hospital channel, funded entirely from internal accruals.

Verify on exchange BSE filings for JAGSNPHARM NSE filings for JAGSNPHARM Tijori Finance company page